219 related articles for article (PubMed ID: 26960442)
21. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
[TBL] [Abstract][Full Text] [Related]
23. Non-enhanced trabeculectomy by non-glaucoma specialists: are results related to risk factors for failure?
Sung VC; Butler TK; Vernon SA
Eye (Lond); 2001 Feb; 15(Pt 1):45-51. PubMed ID: 11318294
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
25. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
[TBL] [Abstract][Full Text] [Related]
26. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
27. Conservative management of suspicious melanocytic lesions of the iris.
Oxenreiter MM; Lane AM; Jain P; Kim IK; Gragoudas ES
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1319-1324. PubMed ID: 30919077
[TBL] [Abstract][Full Text] [Related]
28. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of proton beam irradiated uveal melanomas.
Gragoudas ES; Seddon JM; Egan K; Glynn R; Munzenrider J; Austin-Seymour M; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1987 Apr; 94(4):349-53. PubMed ID: 3035451
[TBL] [Abstract][Full Text] [Related]
30. Posterior uveal melanoma in young patients treated with proton beam therapy.
Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
[TBL] [Abstract][Full Text] [Related]
31. Intraocular recurrence of uveal melanoma after proton beam irradiation.
Gragoudas ES; Egan KM; Seddon JM; Walsh SM; Munzenrider JE
Ophthalmology; 1992 May; 99(5):760-6. PubMed ID: 1594223
[TBL] [Abstract][Full Text] [Related]
32. [Rapidly progressing cataract in contact with ciliary body melanoma after proton-beam irradiation].
Msika LC; Matet A; Dendale R; Vandermeer G; Levy C
J Fr Ophtalmol; 2019 Mar; 42(3):e115-e116. PubMed ID: 30833006
[No Abstract] [Full Text] [Related]
33. Outcomes and complications of trabeculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis.
Chawla A; Mercieca K; Fenerty C; Jones NP
J Glaucoma; 2013; 22(8):663-6. PubMed ID: 22706335
[TBL] [Abstract][Full Text] [Related]
34. Treatment of uveal melanoma by accelerated proton beam.
Desjardins L; Lumbroso-Le Rouic L; Levy-Gabriel C; Cassoux N; Dendale R; Mazal A; Delacroix S; Sastre X; Plancher C; Asselain B
Dev Ophthalmol; 2012; 49():41-57. PubMed ID: 22042012
[TBL] [Abstract][Full Text] [Related]
35. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
37. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
[TBL] [Abstract][Full Text] [Related]
38. Three-year follow-up of the tube versus trabeculectomy study.
Gedde SJ; Schiffman JC; Feuer WJ; Herndon LW; Brandt JD; Budenz DL;
Am J Ophthalmol; 2009 Nov; 148(5):670-84. PubMed ID: 19674729
[TBL] [Abstract][Full Text] [Related]
39. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
40. Proton beam therapy of parapapillary choroidal melanoma.
Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]